Drug stocks can be somewhat volatile. Things like clinical setbacks or patent cliffs can sink their stock prices or erode ...

This Chase cash back card is offering one of the easiest-to-earn bonuses I've ever seen. Read on to learn why now's the time ...

Learn how this Wells Fargo card can earn you $600+ in value in year one -- and how it can beat out all the competition.

Part of Greece's plan to upgrade its military capabilities just cleared a major hurdle.

Artificial intelligence (AI) will likely create more success stories that people will look back on 10 or 20 years from now ...

Ride-sharing company Uber Technologies (UBER 1.60%) is throwing its hat in the robotaxi ring. Yesterday, Uber inked a $1.25 ...

While both Microsoft and Alphabet are expanding their businesses to include AI integration, each has a core business that ...

Want to rack up 3X points on every booked flight, dinner on the town, and more? Here's the card to get, plus other great ...

The network organizes contributors into specialized subnetworks, with each focused on a specific AI task like text generation ...

Abivax and Nektar Therapeutics are clinical-stage biotech companies that would make attractive buyout targets.

Usually, when a company delivers blowout earnings, issues highly optimistic guidance, and raises its dividend by 30% (yes, ...

Robinhood's business is showing cracks, which is causing investors to rethink the company's sky-high valuation.